Current Cardiology Reports

, 15:385 | Cite as

Continuous Positive Airway Pressure and Cardiovascular Events in Patients with Obstructive Sleep Apnea

Ischemic Heart Disease (D Mukherjee, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Ischemic Heart Disease

Abstract

The obstructive sleep apnea syndrome (OSAS) is associated with the development/worsening of cardiovascular disease. OSAS is considered to be an independent risk factor for hypertension and is linked to increased mortality in the context of coronary heart disease, the development of cardiac arrhythmias and increased risk of developing mild pulmonary hypertension. OSAS is also associated with cerebrovascular mortality and morbidity. In heart failure, OSAS can lead to worsening of symptoms. Treatment of OSAS using positive airways pressure therapy (PAP) has been shown in randomized, controlled trials in selected populations to reduce some, but not all of these cardiovascular and cerebrovascular risks. Unequivocal evidence of causality for OSAS in the development, progression, and outcomes of these disorders in all individuals suffering from them, is lacking. Good quality long-term morbidity and mortality data for the effects of OSAS on cardiometabolic health and the impact of PAP treatment are likewise limited.

Keywords

Continuous positive airway pressure CPAP Obstructive sleep apnea Heart failure Cardiovascular disease Cerebrovascular disease Review 

Notes

Compliance with Ethics Guidelines

Conflict of Interest

Athanasia Pataka declares that she has no conflict of interest.

Renata L. Riha declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53.PubMedGoogle Scholar
  2. 2.
    Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnea in adults. Cochrane Database Syst Rev. 2006;3, CD001106.PubMedGoogle Scholar
  3. 3.
    Jennum P, Riha RL. Epidemiology of sleep apnea/hypoapnea syndrome and sleep-disordered breathing. Eur Respir J. 2009;33:907–14.PubMedCrossRefGoogle Scholar
  4. 4.
    Marler M. The relationship between congestive heart failure, sleep apnea, and mortality in older men. Chest. 2003;124:1400–5.PubMedCrossRefGoogle Scholar
  5. 5.
    Hu FB, Willett WC, Manson JE, Colditz GA, Rimm EB, Speizer FE, et al. Snoring and risk of cardiovascular disease in women. J Am Coll Cardiol. 2000;35:308–13.PubMedCrossRefGoogle Scholar
  6. 6.
    Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA. 2000;283:1829–36.PubMedCrossRefGoogle Scholar
  7. 7.
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.PubMedCrossRefGoogle Scholar
  8. 8.
    Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;163:19–25.PubMedCrossRefGoogle Scholar
  9. 9.
    Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J. 2004;25:735–41.PubMedCrossRefGoogle Scholar
  10. 10.
    McNicholas WT, Bonsigore MR. Sleep apnea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms, and research priorities. Management Committee of EU COST ACTION B26. Eur Respir J. 2007;29:156–78.PubMedCrossRefGoogle Scholar
  11. 11.
    Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Bradley TD, Floras JS. Obstructive sleep apnea and its cardiovascular consequences. Lancet. 2009;373:82–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Ferrier K, Campbell A, Yee B, Richards M, O'Meeghan T, Weatherall M, et al. Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest. 2005;128:2116–22.PubMedCrossRefGoogle Scholar
  14. 14.
    Wang H, Parker JD, Newton GE, Floras JS, Mak S, Chiu KL, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49:1625–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Naughton MT, Bradley TD. Sleep apnea in congestive heart failure. Clin Chest Med. 1998;19:99–113.PubMedCrossRefGoogle Scholar
  16. 16.
    Koehnlein T, Welte T, Tan LB, Elliott MW. Central sleep apnea syndrome in patients with chronic heart disease: a critical review of the current literature. Thorax. 2002;57:547–54.CrossRefGoogle Scholar
  17. 17.
    Riha RL. Clinical assessment of the obstructive sleep apnea/hypoapnea syndrome. Ther Adv Respir Dis. 2010;4:83–91.PubMedCrossRefGoogle Scholar
  18. 18.
    Leung RS, Bradley TD. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med. 2001;164:2147–65.PubMedCrossRefGoogle Scholar
  19. 19.
    McNicholas WT. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease. Am J Respir Crit Care Med. 2009;180:692–700.PubMedCrossRefGoogle Scholar
  20. 20.
    Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, et al. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation. 2010;121:1598–605.PubMedCrossRefGoogle Scholar
  21. 21.
    Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378–84.PubMedCrossRefGoogle Scholar
  22. 22.
    O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179:1159–64.Google Scholar
  23. 23.
    Jones A, Vennelle M, Connell M, McKillop G, Newby DE, Douglas NJ, et al. Arterial stiffness and endothelial function in obstructive sleep, Apnea/Hypopnea Syndrome. Sleep Med. (in press).Google Scholar
  24. 24.
    Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417–23.PubMedCrossRefGoogle Scholar
  25. 25.
    •• Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. European Respiratory Society; EU COST ACTION B26 members. Position paper on the management of patients with obstructive sleep apnea and hypertension: joint recommendations by the European Society of Hypertension, by the European Respiratory Society, and by the members of European COST (COoperation in Scientific and Technological research) ACTION B26 on obstructive sleep apnea. J Hypertens. 2012;30:633–46. Most complete and up-to-date consensus guidelines for assessing hypertension in the context of obstructive sleep apnea and vice versa.Google Scholar
  26. 26.
    Butt M, Dwivedi G, Shantsila A, Khair OA, Lip GY. Left ventricular systolic and diastolic function in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Circulation: Heart Failure. 2012;5:226–33.Google Scholar
  27. 27.
    Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med. 2007;167:757–64.PubMedCrossRefGoogle Scholar
  28. 28.
    Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, Merino-Sanchez M, Gonzalez-Benitez MA, Beltran-Robles M, Almeida-Gonzalez C. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest. 2006;129:1459–67.Google Scholar
  29. 29.
    Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229–35.Google Scholar
  30. 30.
    Barbé F, Mayoralas LR, Duran J, Masa JF, Maimó A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness. a randomized, controlled trial. Ann Intern Med. 2001;134:1015–23.Google Scholar
  31. 31.
    •• Barbé F, Durán-Cantolla J, Sánchez-de-la-Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in non-sleepy patients with obstructive sleep apnea: a randomized controlled trial. JAMA. 2012;307:2161–8. Well-performed trial looking at hypertension and OSA in a large, multi-centers Spanish population.Google Scholar
  32. 32.
    Arias MA, García-Río F, Alonso-Fernández A, Martínez I, Villamor J. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106–13.Google Scholar
  33. 33.
    Sajkov D, McEvoy RD. Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis. 2009;51:363.PubMedCrossRefGoogle Scholar
  34. 34.
    Kuniyoshi FH, Garcia-Touchard A, Gami AS, Romero-Corral A, van der Walt C, Pusalavidyasagar S, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008;52:343–6.PubMedCrossRefGoogle Scholar
  35. 35.
    Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001;3:19–25.CrossRefGoogle Scholar
  36. 36.
    Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Javier Nieto F, et al. Sleep disordered breathing and mortality: 18-year follow-up of the Wisconsin Sleep Cohort. Sleep. 2008;31:1071–8.PubMedGoogle Scholar
  37. 37.
    Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnea: a long-term follow-up. Eur Respir J. 2006;28:596.PubMedCrossRefGoogle Scholar
  38. 38.
    Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnea with myocardial infarction in men. Lancet. 1990;336:261.PubMedCrossRefGoogle Scholar
  39. 39.
    Yumino D, Tsurumi Y, Takagi A, Suzuki K, Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99:26–30.Google Scholar
  40. 40.
    Saletu M, Sauter C, Lalouschek W, Saletu B, Kapfhammer G, Benesch T, et al. Is excessive daytime sleepiness a predictor of carotid atherosclerosis in sleep apnea? Atherosclerosis. 2008;196:810–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Scharf SM, Bianco JA, Tow DE, Brown R. The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary a2tery disease. Circulation. 1981;63:871–5.PubMedCrossRefGoogle Scholar
  42. 42.
    Can M, Açikgöz S, Mungan G, Bayraktaroğlu T, Koçak E, Güven B, Demirtas S. Serum cardiovascular risk factors in obstructive sleep apnea. Chest. 2006;129:23–7.Google Scholar
  43. 43.
    Buchner NJ, Sanner BM, Borgel J, Rump LC. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med. 2007;176:1274.PubMedCrossRefGoogle Scholar
  44. 44.
    Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnea and nocturnal angina. Lancet. 1995;345:1085–7.PubMedCrossRefGoogle Scholar
  45. 45.
    Mohsenin V. Sleep-related breathing disorders and risk of stroke. Stroke. 2001;32:1271–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Arzt M, Yount T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–51.PubMedCrossRefGoogle Scholar
  47. 47.
    McArdle N, Riha RL, Vennelle M, Coleman EL, Dennis MS, Warlow CP, Douglas NJ. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case–control study in patients with transient ischemic attacks. Stroke. 2003;34:2916–21.Google Scholar
  48. 48.
    Hsu CY, Vennelle M, Li HY, Engleman HM, Dennis MS, Douglas NJ. Sleep-disordered breathing after stroke: a randomized controlled trial of continuous positive airway pressure. J Neurol Neurosurg Psychiatr. 2006;77:1143–9.Google Scholar
  49. 49.
    Lee SA, Amis TC, Byth K, Larcos G, Kairaitis K, Robinson TD, et al. Heavy snoring as a cause of carotid artery atherosclerosis. Sleep. 2008;31:1207–13.PubMedGoogle Scholar
  50. 50.
    Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H, Franklin KA. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med. 2008;168:297–301.Google Scholar
  51. 51.
    Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L, Soriano Y, Román-Sánchez P, Illa FB, et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea. a 5-year follow-up study. Am J Respir Crit Care Med. 2009;180:36–41.Google Scholar
  52. 52.
    Parra O, Arboix A, Montserrat JM, Quintó L, Bechich S, García-Eroles L. Sleep-related breathing disorders: impact on mortality of cerebrovascular disease. Eur Respir J. 2004;24:267–72.Google Scholar
  53. 53.
    Martínez-García MA, Galiano-Blancart R, Román-Sánchez P, Soler-Cataluña JJ, Cabero-Salt L, Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest. 2005;128:2123–9.Google Scholar
  54. 54.
    • Martínez-García MA, Campos-Rodríguez F, Soler-Cataluña JJ, Catalán-Serra P, Román-Sánchez P, Montserrat JM. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnea: effect of CPAP treatment. Eur Respir J. 2012;39:906–12. Well-conducted multicenter trial from Spain assessing CPAP treatment in stroke patients.PubMedCrossRefGoogle Scholar
  55. 55.
    Wessendorf TE, Wang YM, Thilmann AF, Sorgenfrei U, Konietzko N, Teschler H. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure in stroke. Eur Respir J. 2001;18:623–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Palombini L, Guilleminault C. Stroke and treatment with nasal CPAP. Eur J Neurol. 2006;13:198–200.PubMedCrossRefGoogle Scholar
  57. 57.
    Sandberg O, Franklin KA, Bucht G, Eriksson S, Gustafson Y. Nasal continuous positive airway pressure in stroke patients with sleep apnea: a randomized treatment study. Eur Respir J. 2001;18:630–4.PubMedCrossRefGoogle Scholar
  58. 58.
    Scala R, Turkington PM, Wanklyn P, Bamford J, Elliott MW. Acceptance, effectiveness and safety of continuous positive airway pressure in acute stroke: a pilot study. Respir Med. 2009;103:59–66.PubMedCrossRefGoogle Scholar
  59. 59.
    Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation. 1998;97:2154–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Arzt M, Young T, Finn L, Skatrud JB, Ryan CM, Newton GE, et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med. 2006;166:1716–22.PubMedCrossRefGoogle Scholar
  61. 61.
    Barbe F, Mayoralas LR, Duran J, Masa JF, Maimo A, Montserrat JM, et al. Treatment with continuous positive airway pressure is not effective in patients with sleep apnea but no daytime sleepiness; a randomized, controlled trial. Ann Intern Med. 2001;134:1015–23.PubMedCrossRefGoogle Scholar
  62. 62.
    Robinson GV, Smith DM, Langford BA, Davies RJ, Stradling JR. Continuous positive airway pressure does not reduce blood pressure in non-sleepy hypertensive OSA patients. Eur Respir J. 2006;27:1229–35.PubMedCrossRefGoogle Scholar
  63. 63.
    Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388–442.Google Scholar
  64. 64.
    Masip J, Roque M, Sanchez B, Fernandez R, Subirana M, Exposito JA. Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis. JAMA. 2005;294:3124–30.PubMedCrossRefGoogle Scholar
  65. 65.
    Peter JV, Moran JL, Phillips-Hughes J, Graham P, Bersten AD. Effect of non-invasive positive pressure ventilation (NIPPV) on mortality in patients with acute cardiogenic pulmonary edema: a meta-analysis. Lancet. 2006;367:1155–63.PubMedCrossRefGoogle Scholar
  66. 66.
    Vital FM, Saconato H, Ladeira MT, Sen A, Hawkes CA, Soares B, et al. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary edema. Cochrane Database Syst Rev. 2008;3, CD005351.PubMedGoogle Scholar
  67. 67.
    Naughton MT, Benard DC, Liu PP, Rutherford R, Rankin F, Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med. 1995;152:473–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Bradley TD, Logan AG, Kimoff RJ, Series F, Morrison D, Ferguson K, et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med. 2005;353:2025–33.PubMedCrossRefGoogle Scholar
  69. 69.
    Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation. 2000;102:61–6.PubMedCrossRefGoogle Scholar
  70. 70.
    Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D, et al. CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation. 2007;115:3173–80.PubMedCrossRefGoogle Scholar
  71. 71.
    Arzt M, Schulz M, Schroll S, Budweiser S, Bradley TD, Riegger GA, et al. Time course of continuous positive airway pressure effects on central sleep apnea in patients with chronic heart failure. J Sleep Res. 2009;18:20–5.PubMedCrossRefGoogle Scholar
  72. 72.
    Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998;98:2269–75.PubMedCrossRefGoogle Scholar
  73. 73.
    Khayat RN, Abraham WT, Patt B, Roy M, Hua K, Jarjoura D. Cardiac effects of continuous and bilevel positive airway pressure for patients with heart failure and obstructive sleep apnea: a pilot study. Chest. 2008;134:1162.PubMedCrossRefGoogle Scholar
  74. 74.
    Sharma BK, Bakker JP, McSharry DG, Desai AS, Javaheri S, Malhotra A. Adaptive servo-ventilation for treatment of sleep-disordered breathing in heart failure: a systematic review and meta-analysis. Chest. 2012.Google Scholar
  75. 75.
    Kasai T, Usui Y, Yoshioka T, Yanagisawa N, Takata Y, Narui K, et al. JASV Investigators. Effect of flow-triggered adaptive servo-ventilation compared with continuous positive airway pressure in patients with chronic heart failure with coexisting obstructive sleep apnea and Cheyne-Stokes respiration. Circ Heart Fail. 2010;3:140–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Otsuka K, Sadakane N, Ozawa T. Arrythmogenic properties of disordered breathing during sleep in patients with cardiovascular disorders. Clin Cardiol. 1987;10:771–82.PubMedCrossRefGoogle Scholar
  77. 77.
    Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Sleep Heart Health Study Association of nocturnal arrhythmias with sleep-disordered breathing. Am J Respir Crit Care Med. 2006;173:910–6.PubMedCrossRefGoogle Scholar
  78. 78.
    Simantirakis EN, Schiza SI, Marketou ME, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, et al. Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J. 2004;25:1070–6.Google Scholar
  79. 79.
    Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–94.Google Scholar
  80. 80.
    Garrigue S, Bordier P, Jais P, Shah DC, Hocini M, Raherison C, et al. Benefit of atrial pacing in sleep apnea syndrome. N Engl J Med. 2002;346:4404–12.CrossRefGoogle Scholar
  81. 81.
    Luthje L, Renner B, Kessels R, Vollmann D, Raupach T, Gerritse B, et al. Cardiac resynchronization therapy and atrial overdrive pacing for the treatment of central sleep apnea. Eur J Heart Fail. 2009;11:273–80.PubMedCrossRefGoogle Scholar
  82. 82.
    Pepin JL, Defaye P, Garrigue S, Poezevara Y, Levy P. Overdrive pacing does not improve obstructive sleep apnea syndrome does not improve obstructive sleep apnea syndrome. Eur Respir J. 2005;25:343–7.PubMedCrossRefGoogle Scholar
  83. 83.
    Simantirakis EN, Schiza SE, Chrysostomakis SI, Chlouverakis GI, Klapsinos NC, Siafakas NM, et al. Atrial overdrive pacing for the obstructive sleep apnea-hypopnea syndrome. N Engl J Med. 2005;353:2568–77.PubMedCrossRefGoogle Scholar
  84. 84.
    Sharafkhaneh A, Sharafkhaneh H, Bredikus A, Guilleminault C, Bozkurt B, Hirshkowitz M. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007;8:31–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Respiratory Medicine, Respiratory Failure Unit, G. Papanikolaou HospitalUniversity of ThessalonikiThessalonikiGreece
  2. 2.Department of Sleep MedicineRoyal Infirmary of EdinburghEdinburghUK

Personalised recommendations